BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirshahi F, Aqbi HF, Isbell M, Manjili SH, Guo C, Saneshaw M, Dozmorov M, Khosla A, Wack K, Carrasco-Zevallos OM, Idowu MO, Wang XY, Sanyal AJ, Manjili MH, Bandyopadhyay D. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. Cell Rep 2022;38:110454. [PMID: 35235789 DOI: 10.1016/j.celrep.2022.110454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Ding M, Bai J, Luo R, Liu R, Qu J, Li X. Decoding the role of immune T cells: A new territory for improvement of metabolic‐associated fatty liver disease. iMeta 2023. [DOI: 10.1002/imt2.76] [Reference Citation Analysis]
2 Mao T, Yang R, Luo Y, He K. Crucial role of T cells in NAFLD-related disease: A review and prospect. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1051076] [Reference Citation Analysis]
3 Montgomery EJ, Xing E, Campbell MJ, Li PK, Blachly JS, Tsung A, Coss CC. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. Int J Mol Sci 2022;23. [PMID: 36430245 DOI: 10.3390/ijms232213768] [Reference Citation Analysis]
4 Isbell M, Mirshahi F, Aqbi HF, Guo C, Saneshaw M, Koelsch N, Idowu MO, Austin D, Gelber C, Wang XY, Sanyal AJ, Manjili MH. Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC. Cancers (Basel) 2022;14. [PMID: 36428596 DOI: 10.3390/cancers14225502] [Reference Citation Analysis]
5 Maciel Costa Silva RC, Lopes MF, Travassos Correa LH. Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus. Cancer Pathogenesis and Therapy 2022. [DOI: 10.1016/j.cpt.2022.11.001] [Reference Citation Analysis]
6 Tu T, Alba MM, Datta AA, Hong H, Hua B, Jia Y, Khan J, Nguyen P, Niu X, Pammidimukkala P, Slarve I, Tang Q, Xu C, Zhou Y, Stiles BL. Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis. Front Oncol 2022;12:958696. [DOI: 10.3389/fonc.2022.958696] [Reference Citation Analysis]